Literature DB >> 6783409

Dexamethasone-binding proteins in cytosol and nucleus of rat thymocytes. Purification of three receptor proteins.

N G Tsawdaroglou, M V Govindan, W Schmid, C E Sekeris.   

Abstract

Dexamethasone-binding proteins from the cytosol and the nucleus of rat thymocytes were analyzed by ion-exchange chromatography on DEAE-cellulose. Three dexamethasone-binding proteins were revealed in cytosol, one in the flow-through (DE-1) and two (DE-2 and DE-3) eluting from the column with 0.13 M and 0.23 M NH4Cl, respectively. In nuclear extracts only one receptor fraction, present in the flow-through, could be detected. By a combination of affinity chromatography on Cl-Sepharose to which dexamethasone 21-methanesulfonate was linked through a disulufide bond and DEAE-cellulose chromatography, three receptor proteins were highly purified from cytosol, with molecular weights of 45 000, 72 000 and 90 000 and one from nuclear extracts with molecular weight of 72 000. Antibodies to the 45 000-Mr and 90 000-Mr proteins were elicited in rabbits. The antibodies to the 45 000-Mr protein cross-react with the 90 000-Mr. Similarly, the antibodies to the 90 000-Mr protein cross-react with the 45 000-Mr protein. Antibodies to either of the two proteins immunoprecipitate 60--70% of the dexamethasone-binding activity of rat thymus cytosol. Immunoaffinity chromatography of cytosol and nucleosol on columns of Sepharose linked to the IgG against either the 45 000-Mr or the 90 000-Mr protein leads to binding of these proteins on the columns but not of the 72 000-Mr species. Two nuclear polypeptides with molecular weights of 36 000 and 38 000 remain attached to the immunoaffinity column; these polypeptides may represent degradation products of the cytoplasmic receptor upon entrance into the nucleus. Antibodies against two dexamethasone-binding proteins from rat liver cytosol immunoprecipitate the 45 000-Mr cytosol receptors from rat thymus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6783409     DOI: 10.1111/j.1432-1033.1981.tb05150.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

2.  Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains.

Authors:  J Carlstedt-Duke; S Okret; O Wrange; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

3.  Purified glucocorticoid receptor-hormone complex from rat liver cytosol binds specifically to cloned mouse mammary tumor virus long terminal repeats in vitro.

Authors:  M V Govindan; E Spiess; J Majors
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  Monoclonal antibodies against the rat liver glucocorticoid receptor.

Authors:  S Okret; A C Wikström; O Wrange; B Andersson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Immunochemical characterization of wild-type and variant glucocorticoid receptors by monoclonal antibodies.

Authors:  H M Westphal; K Mugele; M Beato; U Gehring
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

6.  Monoclonal antibodies to the rat liver glucocorticoid receptor.

Authors:  H M Westphal; G Moldenhauer; M Beato
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

7.  Lack of Galectin-3 Disrupts Thymus Homeostasis in Association to Increase of Local and Systemic Glucocorticoid Levels and Steroidogenic Machinery.

Authors:  Ednéa Oliveira-de-Abreu; Danielle Silva-Dos-Santos; Ailin Lepletier; Tiago D P Ramos; Rafaella Ferreira-Reis; Larissa Vasconcelos-Fontes; Mariana T Ramos; Rafael C Torres; Vinícius Cotta-de-Almeida; Vinícius de Frias Carvalho; Déa M S Villa-Verde
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.